alveolar
epithelium
serv
barrier
entri
potenti
respiratori
pathogen
alveolar
type
ii
tii
cell
immunomodulatori
function
whether
type
ti
cell
compris
approxim
alveolar
epithelium
also
play
role
immun
unknown
reninangiotensin
system
ra
emerg
import
mediat
inflamm
angiotensinconvert
enzym
element
ra
implic
lung
injuri
hypothes
ti
cell
produc
cytokin
respons
lp
stimul
inflamm
modul
ra
alveolar
ti
cell
isol
adult
spraguedawley
rat
lung
injur
intratrach
instil
lp
pcr
perform
determin
whether
ti
cell
express
transcript
tnfa
baselin
lung
injuri
immunocytochem
protein
analysi
detect
angiotensin
ii
ang
ii
well
angiotensin
type
receptor
type
receptor
ti
cell
separ
cellspecif
respons
primari
ti
cell
isol
cultur
expos
lp
ang
ii
specif
inhibitor
cytokin
product
assay
elisa
lp
stimul
product
cytokin
wherea
losartan
inhibitor
block
element
lpsinduc
cytokin
respons
primari
ti
cell
produc
cytokin
treat
lp
contain
import
compon
ra
modul
lpsinduc
cytokin
product
via
ra
suggest
role
ti
cell
innat
immun
respons
lung
alveolar
epithelium
serv
interfac
organ
environ
provid
tight
barrier
permit
ga
exchang
inhibit
entri
respiratori
pathogen
area
interfac
larg
measur
approxim
human
lung
primarili
compris
two
differ
cell
type
alveolar
type
ti
type
ii
tii
cell
tii
cell
cover
intern
surfac
area
lung
cuboid
diamet
approxim
mm
tii
cell
consid
defend
alveolu
produc
secret
surfact
aid
opson
bacteria
also
releas
cytokin
chemotact
factor
facilit
recruit
inflammatori
cell
site
alveolar
injuri
contrast
ti
cell
cover
remain
lung
intern
surfac
area
larg
extrem
thin
squamou
cell
diamet
measur
mm
ti
cell
thought
particip
inflammatori
respons
cultur
rat
tii
cell
differenti
tilik
cell
produc
interferon
respons
viral
infect
studi
primari
ti
cell
lack
even
though
extens
surfac
area
cover
ti
cell
make
cell
type
pathogen
would
first
encount
upon
enter
distal
lung
reninangiotensin
system
ra
vital
regul
blood
pressur
electrolyt
total
bodi
volum
also
play
role
inflamm
angiotensinogen
agt
cleav
renin
produc
angiotensin
cleav
angiotensinconvert
enzym
ace
produc
ang
ii
effector
molecul
ra
ang
ii
stimul
either
angiotensin
type
receptor
lead
vasoconstrict
hypertens
fibroprolifer
inflamm
angiotensin
type
receptor
lead
opposit
effect
vasodil
rel
hypotens
apoptosi
fibroprotect
lp
increas
ang
ii
concentr
bronchoalveolar
lavag
bal
plasma
rat
may
lead
stimul
promot
cytokin
product
thu
reaffirm
role
ra
inflamm
furthermor
angiotensinconvert
metallopeptidas
primarili
convert
ang
ii
angiotensin
report
alveolar
epithelium
protect
acut
lung
injuri
ali
recombin
attenu
degre
lung
damag
multipl
anim
model
lung
injuri
find
along
fact
ti
cell
line
vast
major
interfac
lung
potenti
environment
pathogen
led
us
hypothes
ti
cell
could
involv
immun
respons
local
ra
within
lung
may
one
mean
ti
cell
could
mediat
inflamm
detail
account
method
provid
onlin
supplement
although
alveolar
type
ii
cell
known
immunomodulatori
function
type
cell
consid
capabl
particip
immun
respons
although
vast
surfac
area
type
cell
suggest
first
cell
type
encount
respiratori
pathogen
enter
distal
air
space
studi
show
type
cell
capabl
produc
cytokin
respons
lp
type
cell
cytokin
express
modul
element
reninangiotensin
system
studi
add
new
data
field
alveolar
inflamm
may
lead
new
therapi
aim
limit
inflamm
injuri
hasten
alveolar
recoveri
repair
institut
anim
care
use
committe
univers
california
san
francisco
san
francisco
veteran
affair
medic
center
rat
anesthet
isofluran
inhal
intratrach
instil
normal
salin
mgkg
lp
escherichia
coli
endotoxin
serotyp
sigmaaldrich
st
loui
mo
anim
kill
hour
later
intraperiton
inject
pentobarbit
mgkg
lung
remov
alveolar
ti
tii
cell
isol
fac
use
antibodi
specif
rat
ti
rat
tii
cell
kind
gift
dr
leland
dobb
univers
california
san
francisco
cell
prepar
contain
contamin
cell
discard
cell
viabl
measur
livedead
kit
invitrogen
carlsbad
ca
biochem
experi
perform
fac
ti
tii
cell
demonstr
puriti
provid
onlin
supplement
use
method
gonzal
hubmayr
wang
colleagu
ti
cell
cultur
transwel
plate
densiti
cellscm
tii
cell
cultur
describ
dobb
allow
recoveri
isol
procedur
overnight
variou
reagent
ad
cell
serumfre
media
lp
mgml
ang
ii
mgml
losartan
lo
sigmaaldrich
multipl
reagent
ad
lp
administ
minut
later
cell
cultur
hour
collect
supernat
cell
quantit
pcr
qpcr
use
evalu
tnfa
agt
mrna
express
ti
tii
cell
uninjur
lpsinjur
rat
lung
cultur
ti
cell
gene
express
assay
purchas
appli
biosystem
carlsbad
ca
rel
amount
mrna
calcul
use
compar
threshold
method
rna
intern
control
protein
lysat
ti
tii
cell
studi
use
standard
western
blot
techniqu
antibodi
includ
abcam
cambridg
bactin
sigmaaldrich
densitometr
quantit
perform
use
imagej
softwar
wwwnihgov
immunohistochemistri
perform
cytocentrifug
prepar
mix
rat
lung
cell
antibodi
includ
tolllik
receptor
santa
cruz
biotechnolog
santa
cruz
ca
ang
ii
raybiotech
norcross
ga
secondari
antibodi
conjug
alexa
fluor
invitrogen
control
slide
use
nonspecif
igg
primari
antibodi
cell
cultur
supernat
assay
tnfa
elisa
accord
manufactur
instruct
r
system
minneapoli
mn
experi
perform
minimum
three
time
unless
otherwis
state
comparison
control
treat
group
use
unpair
student
test
comparison
multipl
group
oneway
anova
follow
post
hoc
analysi
use
bonferroni
test
perform
use
graphpad
prism
version
softwar
graphpad
san
diego
ca
p
consid
signific
freshli
isol
ti
cell
cytokin
mrna
express
upregul
lp
lp
potent
activ
innat
immun
respons
earli
phase
character
increas
bal
polymorphonuclear
leukocyt
cytokin
protein
follow
later
phase
occur
hour
lp
instil
mark
normal
bal
fluid
cytokin
concentr
chose
time
point
examin
ti
cell
cytokin
express
ensur
anim
suffici
injur
anim
administ
intratrach
lp
mgkg
induc
ali
control
anim
instil
normal
salin
ti
tii
cell
isol
fac
hour
later
assay
tnfa
mrna
classic
proinflammatori
cytokin
upregul
lpsinduc
lung
injuri
transcript
tnfa
detect
ti
cell
control
lpsinjur
anim
lp
injuri
significantli
increas
tnfa
transcript
express
ti
cell
compar
ti
control
p
figur
whether
ti
cell
contain
receptor
lp
unknown
therefor
express
ti
cell
assay
via
immunocytochemistri
mix
adult
rat
lung
prepar
uninjur
anim
doublestain
either
ti
tii
cellspecif
antibodi
demonstr
coloc
signal
suggest
presenc
ti
tii
cell
figur
control
imag
exhibit
neg
stain
hypothes
ti
cell
could
modul
inflammatori
respons
lp
via
ra
thu
need
demonstr
ti
cell
contain
crucial
element
ra
mix
lung
cell
prepar
doublestain
antibodi
specif
apic
surfac
either
ti
tii
cell
coloc
specif
cell
membran
visual
color
shift
upon
merg
two
fluoresc
imag
confirm
ti
tii
cell
contain
figur
ti
cell
contain
accord
western
blot
figur
normal
bactin
content
demonstr
tii
cell
approxim
protein
ti
cell
ti
cell
contain
approxim
protein
tii
cell
ang
ii
mediat
effect
ra
via
action
lp
shown
promot
ang
ii
product
mani
cell
type
whether
lp
increas
ang
ii
concentr
ti
cell
known
detect
ang
ii
ti
cell
mix
lung
cell
prepar
lpsinjur
noninjur
rat
lung
use
immunocytochemistri
furthermor
ti
cell
lpstreat
anim
appear
intens
ang
ii
stain
differ
evid
ang
ii
stain
tii
cell
injur
noninjur
lung
figur
qpcr
assay
agt
precursor
ang
ii
demonstr
ti
cell
lpsinjur
rat
contain
higher
concentr
agt
ti
cell
noninjur
rat
p
figur
lpsinjur
tii
cell
also
contain
significantli
agt
transcript
uninjur
control
rat
p
protect
ali
queri
whether
differ
express
injur
noninjur
ti
tii
cell
via
qpcr
reduct
evid
quantiti
transcript
ti
cell
injur
anim
compar
control
cell
figur
tii
cell
concentr
transcript
control
lpstreat
anim
similar
measur
respons
ti
cell
lp
accur
primari
rat
alveolar
ti
cell
isol
via
fac
place
cultur
use
method
outlin
gonzalez
hubmayr
wang
colleagu
cell
allow
recov
isol
fac
procedur
overnight
treatment
mgml
lp
serumfre
media
cell
incub
lp
hour
parallel
time
lp
respons
wholeanim
experi
control
cell
treat
serumfre
media
alon
afterward
supernat
cell
collect
accord
elisa
ti
cell
cultur
supernat
ti
cell
produc
small
amount
tnfa
baselin
pgml
mean
sem
lp
stimul
tnfa
concentr
increas
significantli
pgml
p
figur
likewis
signific
increas
evid
stimul
lp
control
cell
pgml
lp
pgml
p
figur
well
control
cell
pgml
lp
pgml
p
figur
although
exact
mechan
abrog
lung
inflamm
known
could
cleav
ang
ii
upregul
lp
therebi
decreas
abil
ang
ii
act
induc
inflamm
explor
whether
lpsinduc
cytokin
respons
ti
cell
could
attenu
exogen
cell
treat
minut
addit
lp
supernat
collect
hour
later
treatment
lp
treatment
significantli
decreas
concentr
pgml
p
figur
concentr
pgml
p
figur
compar
lpsstimul
cell
alon
chang
tnfa
concentr
lpsstimul
ti
cell
pgml
figur
ang
ii
thought
stimul
induc
inflamm
hypothes
ang
ii
suffici
stimul
cytokin
product
ang
ii
ad
alon
cultur
ti
cell
supernat
collect
hour
later
ang
ii
increas
supernat
cytokin
concentr
control
level
tnfa
pgml
right
densitometri
measur
present
graph
base
densitometri
ti
cell
contain
approxim
less
approxim
tii
cell
losartan
inhibit
product
tnfa
lpstreat
ti
cell
lo
specif
inhibitor
decreas
inflammatori
respons
anim
model
ali
lo
ad
cultur
ti
cell
minut
addit
lp
cytokin
concentr
measur
hour
later
compar
lp
stimul
alon
lo
significantli
inhibit
tnfa
secret
lpsstimul
ti
cell
pgml
p
figur
secret
pgml
p
figur
similarli
reduc
degre
inhibit
statist
signific
figur
activ
yield
vasodilat
fibroprotect
apoptosi
direct
contrast
stimul
cultur
ti
cell
pretreat
pd
minut
lp
stimul
alter
tnfa
pgml
figur
pgml
figur
secret
hour
compar
lp
stimul
alon
concentr
pgml
reduc
pd
administr
decreas
statist
signific
figur
elucid
variou
effect
cultur
ti
cell
ad
reagent
concert
measur
supernat
cytokin
concentr
hour
later
addit
lo
togeth
lp
stimul
predict
reduc
cytokin
concentr
ti
cell
agent
alon
decreas
product
tnfa
concentr
reduc
lo
remain
unchang
exogen
ace
figur
interestingli
tnfa
concentr
ti
cell
pretreat
lo
lp
treatment
significantli
differ
tnfa
concentr
lpsalonetr
cell
pgml
howev
lo
decreas
concentr
pgml
p
figur
concentr
also
decreas
pgml
decreas
reach
statist
signific
figur
determin
whether
inhibit
act
immedi
effector
lpsinduc
signal
act
indirectli
promot
effect
mediat
induc
lp
measur
losinduc
inhibit
cytokin
express
earlier
time
point
ie
hour
although
overal
degre
cytokin
product
slightli
lower
note
hour
expect
lo
reduc
lpsstimul
tnfa
figur
figur
product
respect
n
experi
p
suggest
ra
modul
may
act
directli
lpsinduc
signal
studi
suggest
lp
increas
transcript
lead
cytokin
express
discov
hour
lpstreat
cultur
ti
cell
approxim
transcript
express
control
ti
cell
addit
lo
lp
treatment
brought
transcript
express
back
control
level
find
suggest
may
feedbackinhibit
lo
may
interfer
pathway
figur
barrier
form
alveolar
epithelium
first
line
defens
inhal
pathogen
distal
lung
macrophag
monocyt
along
tii
cell
tradit
consid
cell
trigger
immun
respons
inhal
pathogen
given
ti
cell
cover
major
alveolar
epithelium
postul
ti
cell
would
also
abl
activ
immun
respons
respiratori
pathogen
encount
although
immun
cell
produc
major
total
bal
cytokin
chemokin
precis
pulmonari
cell
involv
specif
contribut
cytokinechemokin
content
bal
entir
known
limit
data
avail
contribut
tii
cell
bal
cytokin
content
data
avail
contribut
primari
ti
cell
first
examin
cytokin
express
ti
tii
cell
anim
injur
intratrach
lp
transcript
tnfa
present
control
uninjur
lpsinjur
ti
cell
similar
result
observ
tii
cell
previous
report
injur
ti
cell
express
significantli
tnfa
mrna
uninjur
ti
cell
wherea
mrna
express
injur
uninjur
ti
cell
remain
similar
induc
product
monocyt
fibroblast
thu
respons
observ
may
preced
nonetheless
result
demonstr
novel
find
primari
ti
cell
contain
necessari
transcript
cytokin
product
wellknown
effect
ra
target
cardiovascular
system
evid
exist
ra
produc
direct
effect
organ
tissu
includ
lung
ang
ii
consid
effector
molecul
ra
interact
gprotein
coupl
receptor
induc
activ
transcript
factor
nfkb
activ
protein
induc
cytokin
express
vasoconstrict
fibroprolifer
retent
na
enhanc
lung
injuri
produc
effect
opposit
stimul
primarili
vasodil
inhibit
cell
growth
apoptosi
ang
ii
convert
ang
ang
act
ma
receptor
produc
effect
similar
activ
thu
balanc
arm
ra
seem
occur
aceang
repres
injurypromot
arm
repres
injuryprotect
arm
postul
lpsstimul
cytokin
product
ti
cell
modul
ra
lp
increas
ang
ii
concentr
certain
cell
type
whether
lp
could
induc
ti
cell
ang
ii
product
unknown
detect
ang
ii
ti
tii
cell
uninjur
injur
rat
lung
ang
ii
stain
appear
brighter
ti
cell
lpsinjur
anim
similar
tii
cell
uninjur
injur
lung
attempt
measur
ang
ii
concentr
via
elisa
supernat
cultur
ti
cell
stimul
lp
result
consist
detect
level
assay
pgml
ultim
surpris
halflif
ang
ii
approxim
minut
plasma
minut
local
tissu
compart
therefor
measur
presenc
precursor
ang
ii
agt
ti
cell
accord
qpcr
agt
express
higher
ti
cell
lpsinjur
rat
compar
uninjur
control
rat
suggest
lp
increas
cytokin
express
ti
cell
increas
agt
convert
ang
ii
ang
ii
act
induc
inflamm
similar
find
evid
tii
cell
inflamm
also
regul
eleg
studi
imai
colleagu
demonstr
protect
natur
ali
mice
develop
sever
ali
recombin
attenu
lung
damag
lpsinjur
lung
detect
approxim
less
transcript
ti
cell
ti
cell
uninjur
lung
hour
differ
transcript
tii
cell
lpstreat
versu
control
anim
murin
model
sever
acut
respiratori
syndrom
sar
total
lung
concentr
decreas
sar
coronaviru
sarscov
downregul
receptor
upon
infect
although
studi
suggest
lp
directli
downregul
express
data
ang
ii
decreas
mrna
certain
cell
type
astrocyt
furthermor
approxim
present
ti
versu
tii
cell
lp
may
increas
ang
ii
ti
cell
ang
ii
may
preferenti
bind
decreas
stimul
may
feed
back
system
reduc
concentr
least
decreas
mrna
lpstreat
ti
tii
cell
differ
receptor
densiti
suggest
differenti
regul
ra
two
cell
type
isol
ti
cell
lpsinjur
rat
lung
studi
effect
inflammatori
milieu
eg
macrophag
endothelia
tii
cell
plasma
factor
surfact
ti
cell
isol
cellspecif
respons
lp
stimul
move
figur
angiotensinogen
precursor
ang
ii
upregul
ti
cell
lp
injuri
ti
tii
cell
isol
via
fac
rat
hour
treatment
intratrach
lp
vehicl
control
angiotensinogen
agt
mrna
concentr
measur
use
qpcr
rel
amount
transcript
found
ti
cell
control
anim
n
uninjur
tii
cell
lower
agt
mrna
concentr
wherea
lp
injuri
increas
agt
concentr
ti
cell
n
p
tii
cell
n
data
express
fold
express
agt
mrna
control
valu
sem
valu
normal
b
lp
injuri
decreas
mrna
express
freshli
isol
ti
cell
mrna
concentr
measur
via
qpcr
freshli
isol
ti
tii
cell
use
fac
rat
treat
intratrach
lp
vehicl
control
hour
reduct
evid
transcript
ti
cell
lpsinjur
anim
n
p
differ
evid
transcript
level
tii
cell
control
injur
anim
n
data
express
fold
express
mrna
control
valu
sem
valu
normal
vitro
model
isol
rel
pure
popul
ti
cell
via
fac
place
cultur
isol
process
fac
alon
may
stimul
cytokin
product
allow
cell
recov
overnight
studi
cell
hour
later
parallel
time
point
use
injur
anim
model
measur
cytokin
concentr
supernat
cultur
primari
ti
cell
accord
elisa
control
ti
cell
produc
minim
amount
three
cytokin
concentr
increas
lp
exposur
recent
report
tnfa
concentr
primari
tii
cell
cultur
rang
approxim
pgml
hour
lp
stimul
dose
rang
mgml
lack
data
cytokin
express
cultur
ti
cell
preclud
similar
comparison
result
ti
cell
appear
involv
rang
tii
cell
publish
concentr
cultur
tii
cell
likewis
within
rang
result
obtain
ti
cell
doserespons
experi
lp
demonstr
mgml
lp
ad
cultur
ti
cell
produc
greatest
degre
tnfa
stimul
although
smaller
concentr
also
increas
tnfa
concentr
desir
maximum
cytokin
express
better
visual
effect
inhibitor
cytokin
product
occur
reliabl
mgml
lp
use
concentr
studi
dose
use
investig
studi
tii
cell
cytokin
express
see
onlin
supplement
ang
ii
alon
ad
ti
cell
increas
cytokin
express
initi
expect
ang
ii
stimul
tnfa
product
epitheli
cell
requir
continu
infus
ang
ii
given
short
halflif
ang
ii
averag
minut
local
tissu
compart
singl
dose
may
insuffici
elicit
signific
cytokin
respons
continu
infus
ang
ii
may
necessari
prompt
signific
cytokin
product
ang
ii
induc
apoptosi
rat
tii
cell
may
also
account
lack
robust
cytokin
express
howev
detect
signific
reduct
ti
cell
viabil
treatment
ang
ii
hour
expect
reduc
endogen
ang
ii
concentr
decreas
cytokin
product
decreas
product
lpsstimul
ti
cell
product
tnfa
cleav
substrat
neurotensin
desarg
bradykinin
lead
proinflammatori
respons
thu
ti
cell
could
antiinflammatori
decreas
proinflammatori
increas
tnfa
inconsist
action
ra
attempt
balanc
physiolog
respons
b
c
figur
cytokin
respons
lp
stimul
ti
cell
modul
reninangiotensin
system
ra
element
cytokin
concentr
supernat
fac
cultur
ti
cell
measur
elisa
pgml
incub
variou
reagent
hour
tabl
demonstr
reagent
ad
differ
seri
cultur
ti
cell
comparison
drawn
refer
lpsstimul
cell
result
express
mean
concentr
cytokin
pgml
sem
cultur
ti
cell
produc
small
amount
tnfa
baselin
n
lp
stimul
significantli
increas
tnfa
releas
n
ang
ii
alon
increas
tnfa
concentr
pretreat
lp
treatment
alter
tnfa
express
baselin
level
howev
pretreat
losartan
lo
lp
treatment
significantli
decreas
tnfa
concentr
n
p
pretreat
inhibitor
pd
lo
lp
treatment
n
produc
chang
tnfa
concentr
compar
lp
alon
b
concentr
increas
significantli
lp
treatment
n
p
result
ang
ii
alon
n
differ
control
sampl
pretreat
lp
treatment
inhibit
compar
lp
alon
n
p
likewis
lo
treatment
also
reduc
lpsstimul
n
p
pd
administ
lp
treatment
significantli
alter
product
n
lo
pretreat
lp
treatment
significantli
decreas
product
n
p
compar
lpstreat
cell
c
lp
treatment
significantli
increas
concentr
control
sampl
n
condit
p
pretreat
lp
treatment
significantli
block
releas
lpsstimul
cell
n
p
pretreat
either
lo
n
lo
n
pd
n
lp
treatment
decreas
absolut
concentr
number
achiev
statist
signific
moreov
concentr
lpstreat
ti
cell
alreadi
reduc
approxim
may
ad
enough
overcom
deficit
induc
lungprotect
effect
howev
doserespons
experi
found
differ
ti
supernat
tnfa
product
addit
mgml
mgml
data
shown
moreov
ti
cell
contain
approxim
tii
cell
suggest
ti
cell
although
produc
cytokin
respons
lp
exposur
may
promin
injuryprotect
rather
injurypromot
arm
ra
lo
decreas
cytokin
concentr
lpsstimul
ti
cell
expect
given
inhibit
decreas
cytokin
product
multipl
cell
anim
model
convers
addit
inhibitor
produc
statist
differ
result
lp
alon
also
expect
trend
toward
decreas
product
evid
may
repres
crossreact
inhibitor
less
studi
angiotensin
receptor
altern
downregul
may
occur
inhibit
thu
reduc
inflammatori
respons
combin
lo
lp
stimul
predict
reduc
cytokin
concentr
ti
cell
agent
alon
decreas
product
tnfa
concentr
significantli
reduc
lo
remain
unchang
exogen
interestingli
tnfa
concentr
ti
cell
pretreat
lo
lp
treatment
significantli
differ
tnfa
concentr
lpsalon
treat
cell
howev
lo
significantli
decreas
concentr
concentr
also
lower
decreas
achiev
statist
signific
find
suggest
tnfa
may
sensit
ang
ii
activ
altern
may
sensit
tnfa
effect
ang
inhibit
inflammatori
respons
note
effect
lo
addit
contrast
although
compon
alon
reduc
cytokin
concentr
lo
increas
cytokin
concentr
prompt
question
whether
may
interact
lo
modifi
reduc
signal
efficaci
lo
independ
downregul
altern
result
suggest
inhibit
may
biolog
signific
respons
ang
ii
may
act
via
lesswel
character
pathway
produc
mix
effect
ace
inhibitor
antagonist
report
attenu
inflammatori
respons
anim
model
ali
similar
largescal
studi
human
yet
perform
precis
mechan
ra
modul
ti
cell
inflamm
remain
elus
see
ra
act
immedi
lpsinduc
signal
observ
effect
aris
indirect
influenc
ra
mediat
produc
lp
measur
tnfa
product
presenc
lp
lo
lp
hour
lp
increas
cytokin
express
although
reduc
level
expect
addit
lo
lp
treatment
significantli
reduc
express
cytokin
suggest
ra
act
rather
quickli
lpsinduc
signal
furthermor
investig
effect
lp
lo
express
cultur
ti
cell
given
studi
suggest
activ
upregul
transcript
express
instead
found
hour
lp
decreas
mrna
express
decreas
could
abrog
addit
lo
lp
treatment
lpsinduc
decreas
express
observ
investig
whole
rat
lung
human
mesangi
cell
find
suggest
lp
may
induc
feedback
inhibit
prevent
unbridl
inflamm
lo
disrupt
feedback
loop
futur
studi
need
determin
whether
mrna
express
translat
similar
protein
result
conclus
demonstr
primari
alveolar
ti
cell
produc
cytokin
respons
lp
show
cell
type
compris
alveolar
epithelium
abl
produc
cytokin
respons
lp
speak
abil
ti
cell
play
role
alveolar
inflamm
b
c
figur
insight
ra
modul
ti
cell
inflamm
lo
decreas
lpsinduc
tnfa
product
within
hour
cultur
ti
cell
treat
serumfre
medium
alon
mgml
lp
lo
lp
tnfa
secret
assay
via
elisa
lo
decreas
lpsinduc
tnfa
within
hour
p
b
lo
decreas
lpsinduc
product
within
hour
cultur
ti
cell
treat
serumfre
medium
alon
mgml
lp
lo
lp
secret
assay
via
elisa
lo
decreas
lpsinduc
product
earli
hour
p
c
lo
disrupt
feedback
inhibit
transcript
express
mrna
concentr
measur
via
qpcr
cultur
ti
cell
treat
lp
lo
lp
hour
control
cell
con
treat
serumfre
medium
reduct
evid
transcript
lpstreat
cell
compar
control
cell
reduct
correct
addit
lo
lp
treatment
n
p
data
express
fold
express
mrna
control
valu
sem
valu
normal
also
demonstr
ti
cell
cytokin
express
modul
element
ra
afford
us
anoth
instrument
verit
orchestra
investig
alveolar
inflammatori
respons
studi
impli
ti
cell
may
serv
target
develop
new
therapeut
prevent
tool
regul
alveolar
inflamm
assist
control
lung
injuri
promot
alveolar
repair
author
disclosur
avail
text
articl
wwwatsjournalsorg
